# Pharmacokinetic Study of Vildagliptin in Patients With Renal Impairment

> **NCT00567047** · PHASE1 · COMPLETED · sponsor: **Novartis** · enrollment: 96 (estimated)

## Conditions studied

- Type-2 Diabetes

## Interventions

- **DRUG:** vildagliptin

## Key facts

- **NCT ID:** NCT00567047
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2009-01
- **Final completion:** —
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2009-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00567047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00567047, "Pharmacokinetic Study of Vildagliptin in Patients With Renal Impairment". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00567047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*